Conversion of normal to malignant phenotype: Telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes

被引:30
作者
Kang, MK
Park, NH
机构
[1] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Inst Dent Res, Los Angeles, CA 90095 USA
关键词
oral cancer; human papillomavirus; genomic instability; telomerase; replicative senescence; keratinocytes;
D O I
10.1177/10454411010120010301
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Normal somatic cells terminate their replicative life span through a pathway leading to cellular senescence, which is triggered by activation of p53 and/or pRb in response to critically shortened telomere DNA. Potentially neoplastic cells must first overcome the senescence checkpoint mechanisms and subsequently activate telomerase to propagate indefinitely. Although telomerase activation is closely associated with cellular immortality, telomerase alone is not sufficient to warrant tumorigenicity. Environmental factors, including chemical carcinogens and viral infection, often contribute to aberrant changes leading to tumorigenic conversion of normal cells. Of particular importance in oral cancer development are tobacco-related chemical carcinogens and human papillomavirus (HPV) infection. To describe the molecular mechanisms by which these environmental factors facilitate the genesis of oral cancer, we first established an in vitro multistep oral carcinogenesis model by sequential exposure of normal human oral keratinocytes (NHOK) to "high risk" HPV and chemical carcinogens. Upon introduction of the HPV genome, the cells bypassed the senescence checkpoint and entered into an extended, but not immortal, life span during which telomere DNA continued to shorten. in a few immortal clones surviving beyond the crisis, we found a marked elevation of telomerase activity and stabilization of telomere length. Furthermore, the E6 and E7 oncoprotems of "high risk" HPV disrupted the cell cycle control and DNA repair in immortalized HOK, and enhanced mutation frequency resulting from genomic instability. However, HPV infection alone failed to give rise to a tumorigenic cell population, which required further exposure to chemical carcinogens in addition to HPV infection. Analysis of the data presented suggests that oral carcinogenesis is a series of discrete genetic alterations that result from a continued genotoxic challenge by environmental risk factors. Our in vitro model may be useful for investigators with interest in furthering our understanding of oral carcinogenesis.
引用
收藏
页码:38 / 54
页数:17
相关论文
共 166 条
[41]   Ethanol upregulates the expression of p21(WAF1/CIP1) and prolongs G(1) transition via a p53-independent pathway in human epithelial cells [J].
Guo, WT ;
Baluda, MA ;
Park, NH .
ONCOGENE, 1997, 15 (10) :1143-1149
[42]   Creation of human tumour cells with defined genetic elements [J].
Hahn, WC ;
Counter, CM ;
Lundberg, AS ;
Beijersbergen, RL ;
Brooks, MW ;
Weinberg, RA .
NATURE, 1999, 400 (6743) :464-468
[43]   TRANSCRIPTION-COUPLED REPAIR AND HUMAN-DISEASE [J].
HANAWALT, PC .
SCIENCE, 1994, 266 (5193) :1957-1958
[44]   COOPERATIVE EFFECT OF ANTISENSE-RB AND ANTISENSE-P53 OLIGOMERS ON THE EXTENSION OF LIFE-SPAN IN HUMAN-DIPLOID FIBROBLASTS, TIG-1 [J].
HARA, E ;
TSURUI, H ;
SHINOZAKI, A ;
NAKADA, S ;
ODA, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 179 (01) :528-534
[45]   TELOMERES SHORTEN DURING AGING OF HUMAN FIBROBLASTS [J].
HARLEY, CB ;
FUTCHER, AB ;
GREIDER, CW .
NATURE, 1990, 345 (6274) :458-460
[46]   CELL-CYCLE CHECKPOINTS, GENOMIC INTEGRITY, AND CANCER [J].
HARTWELL, L ;
WEINERT, T ;
KADYK, L ;
GARVIK, B .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 :259-263
[47]   TELOMERE REDUCTION IN HUMAN COLORECTAL-CARCINOMA AND WITH AGING [J].
HASTIE, ND ;
DEMPSTER, M ;
DUNLOP, MG ;
THOMPSON, AM ;
GREEN, DK ;
ALLSHIRE, RC .
NATURE, 1990, 346 (6287) :866-868
[48]   LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS [J].
HAYFLICK, L .
EXPERIMENTAL CELL RESEARCH, 1965, 37 (03) :614-&
[49]  
HEIMBURGER DC, 1988, JAMA-J AM MED ASSOC, V259, P1525
[50]  
HIYAMA K, 1995, ONCOGENE, V10, P937